Literature DB >> 7042120

Clinical applications of protein determinations in biological fluids other than blood.

L M Killingsworth.   

Abstract

Over the past decade, significant improvements in immunochemical and electrophoretic techniques have enabled collection of heretofore unavailable data on proteins in biological fluids, greatly increasing our understanding of protein physiology in the various body compartments and providing the foundation for clinical use of protein analysis in body fluids. The most striking advance has been in the diagnosis of demyelinating disease through the use of serum/cerebrospinal fluid protein ratios and the morphological evaluation of immunoglobulin banding patterns. These laboratory tests are now considered obligatory for any patient in whom demyelinating disease is suspected as the cause of neurological dysfunction. Cerebrospinal fluid protein data can also be helpful in quantitating the permeability of the blood/cerebrospinal fluid barrier in many inflammatory or infectious central nervous system disorders. Assays of individual proteins in urine can help distinguish between different types of proteinuria, and can give quantitative data on the selectivity of the glomerulus and the reabsorbing capacity of the tubules. The protein content of saliva, synovial fluid, and milk has also been well characterized, and is clinically applicable to a wide range of disorders.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7042120

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  7 in total

1.  Application of an improved biuret method to the determination of total protein in urine and cerebrospinal fluid without concentration step by use of Hitachi 7170 auto-analyzer.

Authors:  X Guobing; J Lili; Z Lihua; X Tiean
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

2.  Regulation of complement by cartilage oligomeric matrix protein allows for a novel molecular diagnostic principle in rheumatoid arthritis.

Authors:  Kaisa E Happonen; Tore Saxne; Anders Aspberg; Matthias Mörgelin; Dick Heinegård; Anna M Blom
Journal:  Arthritis Rheum       Date:  2010-12

3.  Elevated Cerebrospinal Fluid Protein Is Associated with Unfavorable Functional Outcome in Spontaneous Subarachnoid Hemorrhage.

Authors:  Neil A Nadkarni; Matthew B Maas; Ayush Batra; Minjee Kim; Edward M Manno; Farzaneh A Sorond; Shyam Prabhakaran; Andrew M Naidech; Eric M Liotta
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-01-11       Impact factor: 2.136

4.  Blood-CSF barrier permeability and central nervous system immunoglobulin G in schizophrenia.

Authors:  D G Kirch; R C Alexander; R L Suddath; N M Papadopoulos; C A Kaufmann; D G Daniel; R J Wyatt
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation.

Authors:  R Scrivo; P Conigliaro; V Riccieri; M Di Franco; C Alessandri; A Spadaro; R Perricone; G Valesini
Journal:  Clin Exp Immunol       Date:  2015-02       Impact factor: 4.330

Review 6.  Neuropsychiatric Lupus, the Blood Brain Barrier, and the TWEAK/Fn14 Pathway.

Authors:  Ariel D Stock; Jing Wen; Chaim Putterman
Journal:  Front Immunol       Date:  2013-12-25       Impact factor: 7.561

7.  12. The Urinary Proteomics: A Tool to Discover New and Potent Biomarkers for Kidney Damage.

Authors:  Hassan Dihazi
Journal:  EJIFCC       Date:  2009-04-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.